Literature DB >> 22133850

Percutaneous radiofrequency septal reduction for hypertrophic obstructive cardiomyopathy in children.

Narayanswami Sreeram1, Mathias Emmel, Joseph V de Giovanni.   

Abstract

OBJECTIVES: The aim of this study was to assess the efficacy of radiofrequency catheter ablation (RFCA) in the treatment of hypertrophic obstructive cardiomyopathy in children.
BACKGROUND: Hypertrophic obstructive cardiomyopathy is an uncommon cause of left ventricular outflow tract obstruction in children. In symptomatic patients, open heart surgical myectomy has hitherto been the only therapeutic option.
METHODS: In 32 children, at a median age of 11.1 (range 2.9 to 17.5) years and weight of 31 (15 to 68) kg, ablation of the hypertrophied septum was performed using a cool-tip ablation catheter via a femoral arterial approach. The median number of lesions was 27 (10 to 63) and fluoroscopic time was 24 (12 to 60) min.
RESULTS: The majority of patients demonstrated an immediate decrease in the catheter pullback gradient (mean 78.5 ± 26.2 mm Hg pre-RFCA versus mean 36.1 ± 16.5 mm Hg post-RFCA, p < 0.01) and a further reduction in the Doppler echocardiographic gradient (mean 96.9 ± 27.0 mm Hg pre-RFCA versus 32.7 ± 27.1 mm Hg post-RFCA, p < 0.01) at follow-up. One patient died due to a paradoxical increase in left ventricular outflow tract obstruction, and another had persistent atrioventricular block that required permanent pacing. Six patients required further procedures (surgery, pacing, or further RFCA) during a median follow-up of 48 (3 to 144) months.
CONCLUSIONS: The preliminary results of RFCA for septal reduction in children with hypertrophic cardiomyopathy are promising and merit further evaluation.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22133850     DOI: 10.1016/j.jacc.2011.09.020

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy.

Authors:  Dennis Lawin; Thorsten Lawrenz; Kristin Radke; Christoph Stellbrink
Journal:  Clin Res Cardiol       Date:  2021-11-24       Impact factor: 5.460

Review 2.  Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.

Authors:  Daniel J Philipson; Eugene C DePasquale; Eric H Yang; Arnold S Baas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

3.  Medical, surgical and interventional management of hypertrophic cardiomyopathy with obstruction.

Authors:  Sammy Elmariah; Michael A Fifer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

4.  Biventricular / left ventricular pacing in hypertrophic obstructive cardiomyopathy: an overview.

Authors:  Radu Vatasescu; Reinder Evertz; Lluis Mont; Marta Sitges; Josep Brugada; Antonio Berruezo
Journal:  Indian Pacing Electrophysiol J       Date:  2012-05-20

Review 5.  Intervention in HCM: patient selection, procedural approach and emerging techniques in alcohol septal ablation.

Authors:  Robert M Cooper; Adeel Shahzad; Rodney H Stables
Journal:  Echo Res Pract       Date:  2014-10-30

6.  A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.

Authors:  Abhijeet B Shelke; Rajeev Menon; Anuj Kapadiya; Sachin Yalagudri; Daljeet Saggu; Sandeep Nair; C Narasimhan
Journal:  Indian Heart J       Date:  2016-04-14

Review 7.  Hypertrophic Cardiomyopathy-Past, Present and Future.

Authors:  Alphonsus C Liew; Vassilios S Vassiliou; Robert Cooper; Claire E Raphael
Journal:  J Clin Med       Date:  2017-12-12       Impact factor: 4.241

8.  Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.

Authors:  Haonan Yang; Yuan Yang; Yuzhou Xue; Suxin Luo
Journal:  Clin Cardiol       Date:  2020-02-07       Impact factor: 2.882

Review 9.  Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy.

Authors:  Tolga Aksu; Tümer Erdem Güler; Kıvanç Yalın; Şükriye Ebru Gölcük; Kazım Serhan Özcan
Journal:  Anatol J Cardiol       Date:  2016-09       Impact factor: 1.596

Review 10.  Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere.

Authors:  Gabrielle Norrish; Ella Field; Juan P Kaski
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.